Post-Ensartinib Outcomes in Refractory Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

被引：1
|
作者：
Kim, H. [1 ]
Vu, P. [2 ]
Harrow, K. [3 ]
Liang, C. [4 ]
Selvaggi, G. [3 ]
Weihe, E. [2 ]
Mitchell, W. [2 ]
Bazhenova, L. [2 ]
Patel, S. [2 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA USA
[2] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA
[3] Xcovery Holdings Inc, Palm Beach Gardens, AL USA
[4] Xcovery Holdings Inc, Palm Beach Gardens, FL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
NSCLC; ALK; ensartinib;
D O I：
10.1016/j.jtho.2019.08.1208
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.14-57
引用
收藏
页码：S577 / S578
页数：2
相关论文
共 50 条
  • [1] Ensartinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients: Updated Data
    Leal, T.
    Wakelee, H.
    Reckamp, K.
    Waqar, S.
    Patel, S.
    Blumenschein, G.
    Neal, J.
    Harrow, K.
    Holzhausen, A.
    Liang, C.
    Dukart, G.
    Horn, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S156 - S156
  • [2] Intracranial activity of ensartinib in patients with anaplastic lymphoma kinase positive (ALK plus ) non-small cell lung cancer (NSCLC)
    Wakelee, H.
    Reckamp, K. L.
    Leal, T. A.
    Patel, S. P.
    Blumenschein, G.
    Shum, E.
    Nieva, J.
    Oxnard, G.
    Sanborn, R. E.
    Waqar, S.
    Zeman, K.
    Dukart, G.
    Harrow, K.
    Liang, C.
    Holzhausen, A.
    Horn, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer
    Cameron, L. B.
    Hitchen, N.
    Chandran, E.
    Morris, T.
    Manser, R.
    Solomon, B. J.
    Jordan, V
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (01):
  • [4] The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
    Golding, Brandon
    Luu, Anita
    Jones, Robert
    Viloria-Petit, Alicia M.
    MOLECULAR CANCER, 2018, 17
  • [5] The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
    Brandon Golding
    Anita Luu
    Robert Jones
    Alicia M. Viloria-Petit
    Molecular Cancer, 17
  • [6] Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer
    Noh, Ka-Won
    Lee, Mi-Sook
    Lee, Seung Eun
    Song, Ji-Young
    Shin, Hyun-Tae
    Kim, Yu Jin
    Oh, Doo Yi
    Jung, Kyungsoo
    Sung, Minjung
    Kim, Mingi
    An, Sungbin
    Han, Joungho
    Shim, Young Mog
    Zo, Jae Ill
    Kim, Jhingook
    Park, Woong-Yang
    Lee, Se-Hoon
    Choi, Yoon-La
    JOURNAL OF PATHOLOGY, 2017, 243 (03): : 307 - 319
  • [7] Rash and Efficacy in Anaplastic Lymphoma Kinase Positive (ALK plus ) Non-Small Cell Lung Cancer Patients Treated with Ensartinib
    Wakelee, H.
    Reckamp, K.
    Leal, T.
    Chiappori, A.
    Waqar, S.
    Zeman, K.
    Neal, J.
    Liang, C.
    Harrow, K.
    Holzhausen, A.
    Zhou, J.
    Selvaggi, G.
    Horn, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S566 - S566
  • [8] Ceritinib in advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK plus ) non-small cell lung cancer (NSCLC): Results of the ASCEND-1 trial
    Kim, Dong-Wan
    Mehra, Ranee
    Tan, Daniel Shao-Weng
    Felip, Enriqueta
    Chow, Laura Quan Man
    Camidge, D. Ross
    Vansteenkiste, Johan F.
    Sharma, Sunil
    De Pas, Tommaso
    Riely, Gregory J.
    Solomon, Benjamin J.
    Wolf, Juergen
    Thomas, Michael
    Schuler, Martin H.
    Liu, Geoffrey
    Santoro, Armando
    Geraldes, Margarida
    Boral, Anthony
    Yovine, Alejandro Javier
    Shaw, Alice Tsang
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Thromboembolism in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer
    Alexander, Marliese
    Solomon, Benjamin
    Burbury, Kate
    CLINICAL LUNG CANCER, 2018, 19 (01) : E71 - E72
  • [10] Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer
    Zhou, Xiaoyun
    Shou, Jiawei
    Sheng, Jin
    Xu, Chunwei
    Ren, Shengxiang
    Cai, Xiuyu
    Chu, Qian
    Wang, Wenxian
    Zhen, Qinhong
    Zhou, Yuefen
    Li, Wenfeng
    Pan, Hong
    Li, Hongsen
    Sun, Tao
    Cheng, Huanqing
    Wang, Huina
    Lou, Feng
    Rao, Chuangzhou
    Cao, Shanbo
    Pan, Hongming
    Fang, Yong
    CANCER SCIENCE, 2019, 110 (10) : 3382 - 3390
12345